Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, West Midlands, UK.
Birmingham Children's Hospital NHS Foundation Trust, Birmingham, West Midlands, UK.
J Magn Reson Imaging. 2019 Jan;49(1):195-203. doi: 10.1002/jmri.26054. Epub 2018 Apr 26.
Metabolite concentrations are fundamental biomarkers of disease and prognosis. Magnetic resonance spectroscopy (MRS) is a noninvasive method for measuring metabolite concentrations; however, quantitation is affected by T relaxation.
To estimate T relaxation times in pediatric brain tumors and assess how variation in T relaxation affects metabolite quantification.
Retrospective.
Twenty-seven pediatric brain tumor patients (n = 17 pilocytic astrocytoma and n = 10 medulloblastoma) and 24 age-matched normal controls.
FIELD STRENGTH/SEQUENCE: Short- (30 msec) and long-echo (135 msec) single-voxel MRS acquired at 1.5T.
T relaxation times were estimated by fitting signal amplitudes at two echo times to a monoexponential decay function and were used to correct metabolite concentration estimates for relaxation effects.
One-way analysis of variance (ANOVA) on ranks were used to analyze the mean T relaxation times and metabolite concentrations for each tissue group and paired Mann-Whitney U-tests were performed.
The mean T relaxation of water was measured as 181 msec, 123 msec, 90 msec, and 86 msec in pilocytic astrocytomas, medulloblastomas, basal ganglia, and white matter, respectively. The T of water was significantly longer in both tumor groups than normal brain (P < 0.001) and in pilocytic astrocytomas compared with medulloblastomas (P < 0.01). The choline T relaxation time was significantly longer in medulloblastomas compared with pilocytic astrocytomas (P < 0.05), while the T relaxation time of NAA was significantly shorter in pilocytic astrocytomas compared with normal brain (P < 0.001). Overall, the metabolite concentrations were underestimated by ∼22% when default T values were used compared with case-specific T values at short echo time. The difference was reduced to 4% when individually measured water T s were used.
Differences exist in water and metabolite T relaxation times for pediatric brain tumors, which lead to significant underestimation of metabolite concentrations when using default water T relaxation times.
3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:195-203.
代谢物浓度是疾病和预后的基本生物标志物。磁共振波谱(MRS)是一种测量代谢物浓度的非侵入性方法;然而,定量会受到 T 弛豫的影响。
估计儿科脑肿瘤的 T 弛豫时间,并评估 T 弛豫变化如何影响代谢物定量。
回顾性。
27 名儿科脑肿瘤患者(n=17 例毛细胞星形细胞瘤和 n=10 例髓母细胞瘤)和 24 名年龄匹配的正常对照。
磁场强度/序列:在 1.5T 上采集短(30 毫秒)和长回波(135 毫秒)单体素 MRS。
通过将两个回波时间的信号幅度拟合到单指数衰减函数来估计 T 弛豫时间,并使用该弛豫时间来校正代谢物浓度估计值。
对每个组织组的平均 T 弛豫时间和代谢物浓度进行单因素方差分析(ANOVA),并进行配对 Mann-Whitney U 检验。
在毛细胞星形细胞瘤、髓母细胞瘤、基底节和白质中,水的平均 T 弛豫时间分别为 181 毫秒、123 毫秒、90 毫秒和 86 毫秒。在肿瘤组中,水的 T 弛豫时间均明显长于正常脑(P<0.001),在毛细胞星形细胞瘤中明显长于髓母细胞瘤(P<0.01)。与毛细胞星形细胞瘤相比,髓母细胞瘤的胆碱 T 弛豫时间明显延长(P<0.05),而与正常脑相比,毛细胞星形细胞瘤的 NAA T 弛豫时间明显缩短(P<0.001)。总的来说,与短回波时间的特定于病例的 T 值相比,当使用默认 T 值时,代谢物浓度会低估约 22%。当单独测量水 T s 时,差异减少到 4%。
儿科脑肿瘤的水和代谢物 T 弛豫时间存在差异,这导致当使用默认水 T 弛豫时间时,代谢物浓度会显著低估。
3 技术功效:第 2 阶段 J. Magn. Reson. Imaging 2019;49:195-203.